Human antibody therapeutics for viral disease / Scott K. Dessain, editor.

Format:

Book

Contributor:

Dessain, Scott K.

Series:

Current topics in microbiology and immunology ; 317.

Current topics in microbiology and immunology ; 317

Language:

English

Subjects (All):

Immunoglobulins.

Immunoglobulins--Therapeutic use.

Virus diseases--Treatment.

Virus diseases.

Virus diseases--Chemotherapy.

Virus Diseases--therapy.

Antibodies--therapeutic use.

Medical Subjects:

Virus Diseases--therapy.

Antibodies--therapeutic use.

Physical Description:

xi, 188 pages : illustrations (some color) ; 24 cm.

Place of Publication:

Berlin ; New York : Springer Verlag, [2008]

Summary:

The articles in this volume have been selected to demonstrate the progress in the development of human antibody therapeutics for viral disease. Keck et al. review the nature of the immune response to the Hepatitis C virus and the details of viral neutralization by antibodies, providing a conceptual model for the clinical use of HCV-specific antibodies. Huber et al. summarize the initial clinical experiences with antibody therapeutics for Human Immunodeficiency Virus, which can be targeted to either the HIV virion or to host cell proteins. A discussion of the breadth immune strategies that is required to control human rabies is provided by Nagarajan et al., with a particular focus on India and other countries in which rabies is endemic. The development of pavilizumab for RSV prophylaxis is reviewed in Wu et al., in addition to results of antibody optimization studies that provide surprising insights and have broad general implications for anti-viral antibody engineering. Mehlhop and Diamond explicate the biology of West Nile Virus as a general model for flaviviruses, while using their cloned antibodies as a springboard to consider the mechanisms of WNV neutralization. The volume concludes with a description of methods to clone human antibodies in their native configurations, which access a class of antibodies that differ from those obtained by recombinant DNA or transgenic mouse methods.

The articles in this volume are definitive and comprehensive reviews written by experts who have sought to define the principles of viral neutralization by human antibodies. They explore and anticipate the obstacles and opportunities that will be encountered as the power of human antibodies is harnessed to address the vast, un-met need for effective anti-viral therapeutics.

Contents:

Therapeutic control of hepatitis C virus: the role of neutralizing monoclonal antibodies / Z. Y. Keck ... [et al.]

Antibodies for HIV treatment and prevention: window of opportunity? / M. Huber ... [et al.]

Human monoclonal antibody and vaccine approaches to prevent human rabies / T. Nagarajan ... [et al.]

Immunoprophylaxis of RSV infection: advancing from RSV-IGIV to palivizumab and motavizumab / H. Wu ... [et al.]

The molecular basis of antibody protection against West Nile virus / E. Mehlhop ... [et al.]

Exploring the native human antibody repertoire to create antiviral therapeutics / S. K. Dessain ... [et al.].

Notes:

Includes bibliographical references and index.

ISBN:

9783540721444

3540721444

9783540721468

3540721460

OCLC:

166357965